Dr. James Kayvanfar, MD

Dr. Kayvanfar practices at Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital.

Dr. Kayvanfar's NPI, 1548288194, was assigned on July 18, 2006. Dr. Kayvanfar graduated from Albert Einstein College of Medicine in 1988. Dr. Kayvanfar holds California license G72876.

Dr. Kayvanfar's primary practice is Henry Mayo Newhall Hospital, at 23845 McBean Pkwy, Valencia, CA 91355 in Los Angeles County. The practice phone is (661) 253-8000.

Dr. Kayvanfar's primary practice is Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital. Dr. Kayvanfar is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is Henry Mayo Newhall Hospital. Dr. Kayvanfar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kayvanfar practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Kayvanfar's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Kayvanfar is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Kayvanfar is licensed in California.

Dmand AI lists arthritis, back and neck pain treatment without fusion, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, enthesopathy in arms, enthesopathy in foot or ankle and fluid in a joint among the conditions Dr. Kayvanfar treats.

CMS data shows 1,157 Medicare services from Dr. Kayvanfar across 18 procedure codes in 2024, for 247 Medicare patients. Medicare paid $89,044 for them.

CMS counts 247 Medicare patients who saw Dr. Kayvanfar in 2024. The largest group is 75 to 84, with 105 patients. 75% of them have arthritis, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kayvanfar's median patient age at 75, with 62% women.

In 2024, Dr. Kayvanfar wrote 701 Medicare Part D claims for 149 patients. 49% of them were for generic drugs. CMS names the drug for 620 of them, across 11 drugs with 11 or more claims each, at $995,476 in total drug cost. In 2023, CMS named 555 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kayvanfar for performance year 2024, reported individually. Dr. Kayvanfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of lower limb (leg) arthroscopy (minimally invasive joint repair) by Dr. Kayvanfar, more than 90% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 537 general payments to Dr. Kayvanfar from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Globus Medical, Inc. paid the most, $10,934.

Dmand AI lists 1 award for Dr. Kayvanfar.

Dr. Kayvanfar graduated from Albert Einstein College of Medicine in 1988. Dr. Kayvanfar is a member of AAOS.

Dr. Kayvanfar is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.